Rita Deng

Rita focuses her practice on capital market transactions and Hong Kong Listing Rules compliance for Hong Kong-listed companies. She is a native Mandarin speaker and is fluent in English.

Before joining Cooley, Rita worked as an associate for another international law firm.

Representative matters:

Capital markets

• Advised Laopu Gold on its approximately US$116 million Hong Kong initial public offering (IPO)*
• Advised Beijing Luzhu Biotechnology on its approximately US$43 million Hong Kong IPO*
• Advised Hainan Drinda New Energy Technology on its approximately US$180 million Hong Kong IPO*
• Advised Sipai Health Technology on its approximately US$23.7 million Hong Kong IPO*
• Advised Jenscare Scientific on its approximately US$28.6 million Hong Kong IPO*
• Advised Yonghe Medical Group on its approximately US$192 million Hong Kong IPO*
• Advised Acotec Scientific Holdings on its approximately US$210 million Hong Kong IPO*
• Advised Hygeia Healthcare Holdings on its approximately US$286 million Hong Kong IPO*
• Advised Simcere Pharmaceutical Group on its approximately HK$3.57 billion Hong Kong IPO*
• Advised Netjoy Holdings on its approximately HK$1.396 billion Hong Kong IPO*
• Advised Modern Dental Group on its approximately HK$656 million Hong Kong IPO*

Compliance

• Advised Laopu Gold (HKEX: 6181) on its post-listing compliance*
• Advised Sipai Health Technology (HKEX: 0314) on its post-listing compliance*
• Advised Acotec Scientific Holdings (HKEX: 6669) on its post-listing compliance*

Others

• Advised Acotec Scientific Holdings on its approximately US$520 million voluntary partial offer*

* Representation handled before joining Cooley